Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025
Allurion Technologies (NYSE: ALUR), an anti-obesity focused company, has scheduled its fourth quarter 2024 financial results announcement for March 26, 2025. The company will host a conference call and webcast at 8:30 AM ET on the same day to discuss the results and provide a business update.
Investors can access the conference call via phone at (888) 330-3417 (domestic) or +1 646 960 0804 (international) using Conference ID 1905455. A live audio webcast will be available in the Events section of Allurion's Investor Relations website. A replay will be accessible by phone using Access Code 1905455 and through the archived webcast on the company's IR website.
Allurion Technologies (NYSE: ALUR), un'azienda focalizzata sulla lotta all'obesità, ha programmato l'annuncio dei risultati finanziari del quarto trimestre 2024 per il 26 marzo 2025. L'azienda ospiterà una conferenza telefonica e un webcast alle 8:30 AM ET dello stesso giorno per discutere i risultati e fornire un aggiornamento aziendale.
Gli investitori possono accedere alla conferenza telefonica tramite telefono al numero (888) 330-3417 (nazionale) o +1 646 960 0804 (internazionale) utilizzando l'ID Conferenza 1905455. Un webcast audio in diretta sarà disponibile nella sezione Eventi del sito web delle Relazioni con gli Investitori di Allurion. Una registrazione sarà accessibile per telefono utilizzando il Codice di Accesso 1905455 e tramite il webcast archiviato sul sito IR dell'azienda.
Allurion Technologies (NYSE: ALUR), una empresa centrada en la lucha contra la obesidad, ha programado el anuncio de sus resultados financieros del cuarto trimestre de 2024 para el 26 de marzo de 2025. La empresa llevará a cabo una llamada de conferencia y un webcast a las 8:30 AM ET el mismo día para discutir los resultados y proporcionar una actualización empresarial.
Los inversores pueden acceder a la llamada de conferencia por teléfono al (888) 330-3417 (nacional) o +1 646 960 0804 (internacional) utilizando el ID de Conferencia 1905455. Un webcast de audio en vivo estará disponible en la sección de Eventos del sitio web de Relaciones con Inversores de Allurion. Una repetición estará accesible por teléfono utilizando el Código de Acceso 1905455 y a través del webcast archivado en el sitio IR de la empresa.
Allurion Technologies (NYSE: ALUR), 비만 치료에 중점을 둔 회사가 2024년 4분기 재무 결과 발표를 2025년 3월 26일로 예정했습니다. 회사는 같은 날 오전 8시 30분 ET에 결과를 논의하고 사업 업데이트를 제공하기 위해 컨퍼런스 콜 및 웹캐스트를 개최할 것입니다.
투자자들은 전화로 (888) 330-3417 (국내) 또는 +1 646 960 0804 (국제)로 컨퍼런스 콜에 접속할 수 있으며, 회의 ID 1905455를 사용해야 합니다. 생중계 오디오 웹캐스트는 Allurion의 투자자 관계 웹사이트의 이벤트 섹션에서 이용할 수 있습니다. 다시 듣기는 전화로 접근 코드 1905455를 사용하거나 회사의 IR 웹사이트에서 아카이브된 웹캐스트를 통해 이용할 수 있습니다.
Allurion Technologies (NYSE: ALUR), une entreprise axée sur la lutte contre l'obésité, a prévu l'annonce de ses résultats financiers pour le quatrième trimestre 2024 le 26 mars 2025. L'entreprise organisera une conférence téléphonique et un webcast le même jour à 8h30 ET pour discuter des résultats et fournir une mise à jour sur l'activité.
Les investisseurs peuvent accéder à la conférence téléphonique par téléphone au (888) 330-3417 (national) ou +1 646 960 0804 (international) en utilisant l'ID de conférence 1905455. Un webcast audio en direct sera disponible dans la section Événements du site Web des Relations Investisseurs d'Allurion. Un enregistrement sera accessible par téléphone en utilisant le code d'accès 1905455 et via le webcast archivé sur le site IR de l'entreprise.
Allurion Technologies (NYSE: ALUR), ein auf die Bekämpfung von Fettleibigkeit fokussiertes Unternehmen, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal 2024 auf den 26. März 2025 terminiert. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen und ein Unternehmensupdate zu geben.
Investoren können die Telefonkonferenz unter (888) 330-3417 (national) oder +1 646 960 0804 (international) mit der Konferenz-ID 1905455 erreichen. Ein Live-Audio-Webcast wird im Bereich Veranstaltungen der Investor Relations-Website von Allurion verfügbar sein. Eine Wiederholung wird telefonisch mit dem Zugangscode 1905455 und über den archivierten Webcast auf der IR-Website des Unternehmens zugänglich sein.
- None.
- None.
To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (international) and use Conference ID 1905455. To listen to the conference call via live audio webcast, please visit the Events section of Allurion’s Investor Relations website at Allurion - Events & Presentations.
A replay of the conference call will be available by telephone by dialing (800) 770 2030 and using Access Code 1905455. The archived webcast will also be available on Allurion’s Investor Relations website mentioned above.
About Allurion
Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-lessTM gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan. The Allurion Gastric Balloon is an investigational device in
For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250312498792/en/
Global Media and Investor Inquiries
investors@allurion.com
Source: Allurion Technologies, Inc.
FAQ
When will Allurion (ALUR) release its Q4 2024 earnings?
What time is Allurion's (ALUR) Q4 2024 earnings call?
How can investors access Allurion's (ALUR) Q4 2024 earnings call?
Where can I find the replay of Allurion's (ALUR) Q4 2024 earnings call?
